Unknown PHASE2/PHASE3 INTERVENTIONAL NCT00889694

Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis

Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis: a 12-Week, Multiple Centers, Randomized Double-Blind, Positive Drug and Placebo Controlled Clinical Trial

Sponsor: Sun Yat-sen University

Conditions Early Ankylosing Spondylitis

Interventions Sulfasalazine Tripterygium placebo

Updated 6 times since 2017 Last updated: Apr 27, 2009 Started: Oct 31, 2008 Primary completion: Jul 31, 2009 Completion: Aug 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00889694, this PHASE2/PHASE3 trial focuses on Early Ankylosing Spondylitis and remains ongoing. Sponsored by Sun Yat-sen University, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

Status: Enrolling By Invitation → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation PHASE2_PHASE3

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sun Yat-sen University

Data source: Sun Yat-sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.